Cargando…

Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy

A 63-year-old man with a history of hepatitis-B-related hepatocellular carcinoma (HCC) in the left lateral portion of the liver received repeated transcatheter arterial chemoembolization (TACE) and salvage radiotherapy. Two months after completing radiotherapy, he presented with dysphagia, epigastri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hana, Kim, Seung Up, Choi, Junjeong, Park, Jun Yong, Ahn, Sang Hoon, Han, Kwang-Hyub, Chon, Chae Yoon, Park, Young Nyun, Kim, Do Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304605/ https://www.ncbi.nlm.nih.gov/pubmed/21415585 http://dx.doi.org/10.3350/kjhep.2010.16.4.401

Ejemplares similares

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
por: Lee, Yong Kang, et al.
Publicado: (2013)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Grover, Inderpreet, et al.
Publicado: (2014)

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
por: Lee, Jae Seung, et al.
Publicado: (2020)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
por: Jeon, Mi Young, et al.
Publicado: (2019)

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Chon, Young Eun, et al.
Publicado: (2019)

Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
por: Lee, Hyung Soon, et al.
Publicado: (2019)

Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
por: Jeon, Mi Young, et al.
Publicado: (2020)

Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021)

Hepatogastric fistula as a rare complication of pyogenic liver abscess
por: Lee, Kyu Won, et al.
Publicado: (2017)

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Jae Seung, et al.
Publicado: (2021)

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
por: Park, Yehyun, et al.
Publicado: (2019)

The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
por: Choi, Sae Byeol, et al.
Publicado: (2009)

Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan® in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements
por: Jang, Hui Won, et al.
Publicado: (2012)

Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
por: Ji, Suk Kyeong, et al.
Publicado: (2008)

Ruptured Massive Hepatocellular Carcinoma Cured by Transarterial Chemoembolization
por: Lee, Ji Eun, et al.
Publicado: (2020)

Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease
por: Chon, Young Eun, et al.
Publicado: (2014)

Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis
por: Kim, Seung Up, et al.
Publicado: (2012)

Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan(®)) before curative resection of hepatocellular carcinoma: a pilot study
por: Kim, Seung Up, et al.
Publicado: (2008)

Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
por: Seo, Ju Hee, et al.
Publicado: (2013)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
por: Song, Jeong Eun, et al.
Publicado: (2017)

A Unique Finding of Hepatogastric Fistula in Cervical Cancer Liver Metastasis
por: Narayanan, Sankar, et al.
Publicado: (2021)

Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Jeong, Yuri, et al.
Publicado: (2015)

Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
por: Chon, Young Eun, et al.
Publicado: (2012)

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
por: Lee, Hye Won, et al.
Publicado: (2016)

Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
por: Lee, Hye Won, et al.
Publicado: (2016)

Acute Variceal Hemorrhage in Patients with Liver Cirrhosis: Weekend versus Weekday Admissions
por: Byun, Sun Jeong, et al.
Publicado: (2012)

Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Park, Chan, et al.
Publicado: (2021)

Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula
por: Cai, Liang, et al.
Publicado: (2022)

Spontaneous Bacterial Peritonitis in Patients with Hepatitis B Virus-Related Liver Cirrhosis: Community-Acquired versus Nosocomial
por: Kim, Seung Up, et al.
Publicado: (2012)

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma
por: Park, Kil Hyo, et al.
Publicado: (2015)

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Jeong, Shin Ok, et al.
Publicado: (2017)

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
por: Kim, Hee Yeon, et al.
Publicado: (2010)

Hepatoduodenal fistula formation following transcatheter arterial chemoembolization and radiotherapy for hepatocellular carcinoma: treatment with endoscopic Histoacryl injection
por: Jeon, Jaryong, et al.
Publicado: (2014)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
por: Ahn, Sung Soo, et al.
Publicado: (2014)

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma
por: Ha, Yeonjung, et al.
Publicado: (2016)

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
por: Heo, Ja Yoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lfi593on0u8db69d9b5pk4kbnd